Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Multitargeted antimitotic drug achieves tumor regression in vivo

April 17, 2012

Preclinical data support clinical testing of AVEO antibody

April 17, 2012

Novel Astellas histone deacetylase inhibitor has encouraging pharmacokinetics

April 16, 2012

AbGenomics presents antibody conjugates with anticancer activity

April 16, 2012

Antimitotic cancer therapy shows promise in vivo and in vitro

April 16, 2012

GSK AMPK activators are active in diabetes and obesity models

April 16, 2012

New cancer immunotherapy targets ALK-1 and VEGF pathways

April 16, 2012

New candidate cancer therapies under development at AstraZeneca

April 16, 2012

Recombinant heat shock protein reduces atherogenesis in preclinical tests

April 16, 2012

Promising first clinical results reported on Affimed TandAb

April 13, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...